These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2196191)

  • 21. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients.
    Sturis J; Polonsky KS; Shapiro ET; Blackman JD; O'Meara NM; van Cauter E
    Diabetologia; 1992 Jul; 35(7):681-9. PubMed ID: 1644248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2007 Apr; 56(4):1113-9. PubMed ID: 17395750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
    Clore JN; Post EP; Bailey DJ; Nestler JE; Blackard WG
    J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus.
    Hughes TA; Gwynne JT; Switzer BR; Herbst C; White G
    Am J Med; 1984 Jul; 77(1):7-17. PubMed ID: 6377892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
    Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men.
    Rice B; Janssen I; Hudson R; Ross R
    Diabetes Care; 1999 May; 22(5):684-91. PubMed ID: 10332666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of insulin secretion and glycemic response to dietary intervention in non-insulin-dependent diabetes.
    Lomasky SJ; D'Eramo G; Shamoon H; Fleischer N
    Arch Intern Med; 1990 Jan; 150(1):169-72. PubMed ID: 2404478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment.
    Valensi P; Moura I; Le Magoarou M; Pariès J; Perret G; Attali JR
    Diabetes Metab; 1997 Feb; 23(1):51-7. PubMed ID: 9059766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of very-low-calorie diet weight reduction on glucose tolerance, insulin secretion, and insulin resistance in obese non-insulin-dependent diabetics.
    Fukuda M; Tahara Y; Yamamoto Y; Onishi T; Kumahara Y; Tanaka A; Shima K
    Diabetes Res Clin Pract; 1989 Jun; 7(1):61-7. PubMed ID: 2666069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance.
    Yeckel CW; Taksali SE; Dziura J; Weiss R; Burgert TS; Sherwin RS; Tamborlane WV; Caprio S
    J Clin Endocrinol Metab; 2005 Feb; 90(2):747-54. PubMed ID: 15522932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency.
    Sotaniemi EA; Karvonen I
    Diabetes Res; 1989 Jul; 11(3):131-9. PubMed ID: 2697484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the discontinuation of long-term sulfonylurea treatment on blood glucose and insulin secretion in noninsulin-dependent diabetes mellitus.
    Sumi S; Ichihara K; Nonaka K; Tarui S
    Endocrinol Jpn; 1982 Feb; 29(1):41-7. PubMed ID: 7049684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a high-carbohydrate diet on blood glucose, insulin and triglyceride levels in normal and obese subjects and in obese subjects with impaired glucose tolerance.
    Silva ME; Pupo AA; Ursich MJ
    Braz J Med Biol Res; 1987; 20(3-4):339-50. PubMed ID: 3330460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects.
    Marena S; Montegrosso G; De Michieli F; Pisu E; Pagano G
    Acta Diabetol; 1992; 29(1):29-33. PubMed ID: 1520903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.